Global Newcastle Disease Vaccine Market Analysis and Forecast 2024-2030

Global Newcastle Disease Vaccine Market Analysis and Forecast 2024-2030


Summary

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.

Newcastle Disease Vaccine segment by Company

Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Newcastle Disease Vaccine segment by Type

Live Vaccines
Killed Vaccines
Newcastle Disease Vaccine segment by Application

Chicken
Duck & Goose
Other
Newcastle Disease Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Newcastle Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newcastle Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Newcastle Disease Vaccine Market by Type
1.2.1 Global Newcastle Disease Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Market by Application
1.3.1 Global Newcastle Disease Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Newcastle Disease Vaccine Market Dynamics
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Newcastle Disease Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Newcastle Disease Vaccine Revenue by Region
3.2.1 Global Newcastle Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Newcastle Disease Vaccine Revenue by Region (2019-2024)
3.2.3 Global Newcastle Disease Vaccine Revenue by Region (2025-2030)
3.2.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Newcastle Disease Vaccine Sales by Region
3.4.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Newcastle Disease Vaccine Sales by Region (2019-2024)
3.4.3 Global Newcastle Disease Vaccine Sales by Region (2025-2030)
3.4.4 Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Newcastle Disease Vaccine Revenue by Manufacturers
4.1.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Newcastle Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Newcastle Disease Vaccine Sales by Manufacturers
4.2.1 Global Newcastle Disease Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Newcastle Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Newcastle Disease Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
4.7 Global Newcastle Disease Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
4.8.2 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier 3
5 Newcastle Disease Vaccine Market by Type
5.1 Global Newcastle Disease Vaccine Revenue by Type
5.1.1 Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Newcastle Disease Vaccine Sales by Type
5.2.1 Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Newcastle Disease Vaccine Price by Type
6 Newcastle Disease Vaccine Market by Application
6.1 Global Newcastle Disease Vaccine Revenue by Application
6.1.1 Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Newcastle Disease Vaccine Sales by Application
6.2.1 Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Newcastle Disease Vaccine Price by Application
7 Company Profiles
7.1 Merial
7.1.1 Merial Comapny Information
7.1.2 Merial Business Overview
7.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merial Newcastle Disease Vaccine Product Portfolio
7.1.5 Merial Recent Developments
7.2 CEVA
7.2.1 CEVA Comapny Information
7.2.2 CEVA Business Overview
7.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
7.2.5 CEVA Recent Developments
7.3 QYH Biotech
7.3.1 QYH Biotech Comapny Information
7.3.2 QYH Biotech Business Overview
7.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
7.3.5 QYH Biotech Recent Developments
7.4 Ringpu Biology
7.4.1 Ringpu Biology Comapny Information
7.4.2 Ringpu Biology Business Overview
7.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
7.4.5 Ringpu Biology Recent Developments
7.5 Yebio
7.5.1 Yebio Comapny Information
7.5.2 Yebio Business Overview
7.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
7.5.5 Yebio Recent Developments
7.6 Harbin Veterinary Research Institute
7.6.1 Harbin Veterinary Research Institute Comapny Information
7.6.2 Harbin Veterinary Research Institute Business Overview
7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
7.6.5 Harbin Veterinary Research Institute Recent Developments
7.7 Merck Animal Health
7.7.1 Merck Animal Health Comapny Information
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
7.7.5 Merck Animal Health Recent Developments
7.8 DHN
7.8.1 DHN Comapny Information
7.8.2 DHN Business Overview
7.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 DHN Newcastle Disease Vaccine Product Portfolio
7.8.5 DHN Recent Developments
7.9 Zoetis
7.9.1 Zoetis Comapny Information
7.9.2 Zoetis Business Overview
7.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
7.9.5 Zoetis Recent Developments
7.10 ChengDu Tecbond
7.10.1 ChengDu Tecbond Comapny Information
7.10.2 ChengDu Tecbond Business Overview
7.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
7.10.5 ChengDu Tecbond Recent Developments
7.11 Elanco (Lohmann)
7.11.1 Elanco (Lohmann) Comapny Information
7.11.2 Elanco (Lohmann) Business Overview
7.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
7.11.5 Elanco (Lohmann) Recent Developments
7.12 FATRO
7.12.1 FATRO Comapny Information
7.12.2 FATRO Business Overview
7.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
7.12.5 FATRO Recent Developments
7.13 CAVAC
7.13.1 CAVAC Comapny Information
7.13.2 CAVAC Business Overview
7.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
7.13.5 CAVAC Recent Developments
7.14 Vaksindo
7.14.1 Vaksindo Comapny Information
7.14.2 Vaksindo Business Overview
7.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
7.14.5 Vaksindo Recent Developments
8 North America
8.1 North America Newcastle Disease Vaccine Market Size by Type
8.1.1 North America Newcastle Disease Vaccine Revenue by Type (2019-2030)
8.1.2 North America Newcastle Disease Vaccine Sales by Type (2019-2030)
8.1.3 North America Newcastle Disease Vaccine Price by Type (2019-2030)
8.2 North America Newcastle Disease Vaccine Market Size by Application
8.2.1 North America Newcastle Disease Vaccine Revenue by Application (2019-2030)
8.2.2 North America Newcastle Disease Vaccine Sales by Application (2019-2030)
8.2.3 North America Newcastle Disease Vaccine Price by Application (2019-2030)
8.3 North America Newcastle Disease Vaccine Market Size by Country
8.3.1 North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Newcastle Disease Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Newcastle Disease Vaccine Market Size by Type
9.1.1 Europe Newcastle Disease Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Newcastle Disease Vaccine Sales by Type (2019-2030)
9.1.3 Europe Newcastle Disease Vaccine Price by Type (2019-2030)
9.2 Europe Newcastle Disease Vaccine Market Size by Application
9.2.1 Europe Newcastle Disease Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Newcastle Disease Vaccine Sales by Application (2019-2030)
9.2.3 Europe Newcastle Disease Vaccine Price by Application (2019-2030)
9.3 Europe Newcastle Disease Vaccine Market Size by Country
9.3.1 Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Newcastle Disease Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Newcastle Disease Vaccine Market Size by Type
10.1.1 China Newcastle Disease Vaccine Revenue by Type (2019-2030)
10.1.2 China Newcastle Disease Vaccine Sales by Type (2019-2030)
10.1.3 China Newcastle Disease Vaccine Price by Type (2019-2030)
10.2 China Newcastle Disease Vaccine Market Size by Application
10.2.1 China Newcastle Disease Vaccine Revenue by Application (2019-2030)
10.2.2 China Newcastle Disease Vaccine Sales by Application (2019-2030)
10.2.3 China Newcastle Disease Vaccine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Newcastle Disease Vaccine Market Size by Type
11.1.1 Asia Newcastle Disease Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Newcastle Disease Vaccine Sales by Type (2019-2030)
11.1.3 Asia Newcastle Disease Vaccine Price by Type (2019-2030)
11.2 Asia Newcastle Disease Vaccine Market Size by Application
11.2.1 Asia Newcastle Disease Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Newcastle Disease Vaccine Sales by Application (2019-2030)
11.2.3 Asia Newcastle Disease Vaccine Price by Application (2019-2030)
11.3 Asia Newcastle Disease Vaccine Market Size by Country
11.3.1 Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Newcastle Disease Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Newcastle Disease Vaccine Market Size by Type
12.1.1 MEALA Newcastle Disease Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Newcastle Disease Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Newcastle Disease Vaccine Price by Type (2019-2030)
12.2 MEALA Newcastle Disease Vaccine Market Size by Application
12.2.1 MEALA Newcastle Disease Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Newcastle Disease Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Newcastle Disease Vaccine Price by Application (2019-2030)
12.3 MEALA Newcastle Disease Vaccine Market Size by Country
12.3.1 MEALA Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Newcastle Disease Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Newcastle Disease Vaccine Value Chain Analysis
13.1.1 Newcastle Disease Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Newcastle Disease Vaccine Production Mode & Process
13.2 Newcastle Disease Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Newcastle Disease Vaccine Distributors
13.2.3 Newcastle Disease Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings